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AIMS: The purpose of this study was to evaluate lower urinary tract symptoms
(LUTS) in idiopathic normal pressure hydrocephalus (iNPH).
METHODS:Patients with new-onset iNPHwere prospectively evaluated for LUTS
via detailed history and physical, and administration of questionnaires from the
International Consultation on Incontinence to assess incontinence (ICIq-UI),
overactive bladder (ICIq-OAB), and quality of life (ICIq-LUTqol), as well as the
American Urological Association Symptom Score bother scale. All patients with
moderate-to-severe LUTS were offered urodynamic testing. Sub-analysis was
performed based on gender, medical comorbidities, and age.
RESULTS: Fifty-ﬁve consecutive patients with iNPH completed the initial
evaluation and surveys. Total urinary incontinence score was mild to moderate
(8.71 ± 0.64: 0–21 scale) with 90.9% experiencing leakage and 74.5% reporting
urge incontinence. Themost commonOAB symptomwas nocturia (2.2 ± 0.14: 0–4
scale) with urge incontinence the most bothersome (3.71 ± 0.44: 0–10 scale).
Quality-of-life impact was moderate (4.47 ± 0.4: 0–10 scale) and American
Urological Association Symptom Score bother scale was 2.89 ± 0.22 (0–6 scale).
Urodynamics testing revealed 100% detrusor overactivity and mean bladder
capacity of 200 mL. Several differences were identiﬁed based on gender, medical
comorbidities, and age.
CONCLUSIONS: Patients with iNPH present with mild-moderate incontinence of
which nocturia is the most common symptom, urge incontinence the most
bothersome, with 100% of patients having detrusor overactivity. Younger patients
experienced greater bother related to LUTS. To our knowledge, this is the only
prospective evaluation of urinary symptoms in patients with new-onset iNPH.
KEYWORDS
hydrocephalus, lower urinary tract symptoms, NPH, urodynamics
1 | INTRODUCTION
Normal pressure hydrocephalus (NPH) is a neurologic
condition characterized by the triad of gait disturbances,
dementia, and urinary incontinence. It is typically a geriatric
condition, with average onset in the eight to ninth decades.
The prevalence increases with age, and approximately 6% of
individuals 80 years and older will develop or be diagnosed
with idiopathic normal pressure hydrocephalus (iNPH).1 The
diagnosis is made when patients meet standardized criteria
based on evaluation of clinical symptoms, and are found to
have enlarged lateral ventricles on cross-sectional imaging.
Since the initial description of NPH by Hakim and Adams in
Dr. David Ginsberg led the peer-review process as the Associate Editor responsible
for the paper.
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1965,2 many studies have been published with a primary
focus on gait disturbances and dementia. However, little work
has been performed to characterize the lower urinary tract
symptoms (LUTS) in NPH. Urinary incontinence is prevalent
in patients with NPH,3,4 and may be a signiﬁcant source of
bother for patients and caregivers.
NPH can be idiopathic (iNPH) or occur secondarily after
stroke or other central nervous system insults. In patients with
iNPH, urinary incontinence may not be as common as in
secondaryNPH, andmaybemore of a lateﬁnding.4,5 It has also
been suggested (though notwell studied) that increased urinary
frequency and urgency precede urinary incontinence in iNPH
and are more common presenting symptoms than frank
incontinence,3,6 and that urinary symptoms may reﬂect
detrusor overactivity diagnosed urodynamically.6,7 Study of
LUTS is important in iNPH because LUTS can impact overall
patient functional status,8 and evenmorbidity andmortality.9,10
The mainstay of treatment for iNPH is with ventriculo-
peritoneal (VP) shunting.11 Using this surgical method, a
shunt is placed from the lateral ventricles and tunneled
subcutaneously into the peritoneal cavity. With some of the
newer shunts, the pressure gradient can be controlled
remotely in order to improve symptoms.12 Unfortunately,
due to the advanced age and frail nature of most patients
presenting with iNPH, complications from VP shunting can
be quite high.13,14 Therefore, careful selection and counseling
of patients with iNPH regarding expected changes in
LUTS following surgical intervention is an important goal.
The purpose of this investigation was to prospectively
characterize LUTS in new-onset iNPH.
2 | MATERIALS AND METHODS
Our work was supported by a grant from the American
Geriatrics Association, and was performed after approval
from the Virginia Commonwealth University Institutional
Review Board. Patients presenting to a specialized iNPH
clinic and who reported any LUTS were prospectively
enrolled in this study. All patients signed informed consent
prior to being enrolled. Relkin et al.5 previously outlined
strict criteria for the diagnosis of Probable, Possible, or
Unlikely iNPH. All patients enrolled in this study were
evaluated by a dedicated team of neurosurgeons and
neuroscientists, and were diagnosed with Probable iNPH
based on established criteria, including information on onset
and duration of symptoms, gait testing, memory testing,
the presence of urinary incontinence, brain imaging, and
spinal infusion testing.5,15,16 As such, 100% of our patient
population had the classic triad of gait disturbances, cognitive
impairment, and urinary symptoms. Patients who met criteria
for new-onset iNPH were included and are the subject of the
current investigation.
All patients were seen by a single attending neuro-
urologist who performed a standardized history and physical
examination. Recorded data included demographics (age
and gender), medical comorbidities, and prior treatments for
LUTS and incontinence. Patients were administered a
series of validated surveys to assess the type, severity, and
quality-of-life (QOL) impact of LUTS. The surveys included
three from the International Consultation on Incontinence
Questionnaire (ICIq) including the Urinary Incontinence
Short Form (ICIq-UI) to assess the type and severity of
incontinence, the overactive bladder (OAB) questionnaire
(ICIq-OAB) to assess the type and severity of OAB
symptoms, and LUTS QOL questionnaire (ICIq-LUTSqol)
to assess the QOL impact from LUTS. In addition, all patients
were administered the American Urological Association
Symptom Score (AUA-SS) bother question. All surveys were
administered directly by the attending neurourologist with
assistance from care providers if patients had limited
cognitive abilities. LUTS were compared among groups
with respect to gender, medical comorbidities, and age. All
patients with new-onset iNPH reporting moderate-severe
LUTS or bother from LUTS (AUA-SS ≥3) were offered
urodynamic testing to be performed prior to any treatments
for incontinence or surgical interventions for iNPH.
Data were analyzed with assistance from a professional
statistician using SPSS software and are reported as means
with standard errors. Comparisons between groups were
made using student's t-tests or Fisher's Exact tests (two-tailed)
with P< 0.05 considered signiﬁcant.
3 | RESULTS
One hundred ﬁfty-one patients were initially evaluated,
including nine patients with probable iNPH. Thirty-four of
the 93 patients with probable iNPH had been treated with VP
shunting prior to their initial urologic evaluation, and were
excluded from the current study. Another four patients were
excluded due to incomplete evaluation or information,
withdrawal from the study, or death. Fifty-ﬁve consecutive
patients met criteria for new-onset iNPH and were included
for evaluation (Supplemental Fig. S1). Thirty-eight men
(69%) and 17 women (31%) were evaluated, with a mean age
of 77 ± 0.7 years (range 68–86 years). In total, 82% of
patients were found to have signiﬁcant comorbidities (84% of
men and 76% of women). Signiﬁcant comorbidities were
considered diabetes (DM), coronary artery disease (CAD),
chronic obstructive pulmonary disease (COPD), hyperten-
sion (HTN), cancer, seizures, depression, Parkinson's disease,
and Alzheimer's disease. A detailed breakdown of patient
comorbidities is shown in Table 1. There was no statistically
signiﬁcant difference between men and women in terms of
age at the time of enrollment, or medical comorbidities.
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The ICIq-UI Short Form was utilized to evaluate urinary
incontinence. Total urinary incontinence score was mild to
moderate (8.71 ± 0.64: 0–21 scale) with 90.9% experiencing
leakage and 74.5% reporting urge incontinence (Figs. 1A and
2A). The ICIq-OAB questionnaire was used to evaluate OAB
symptoms, and the most common symptom was two times/
night nocturia (2.2 ± 0.14: 0–4 scale), with urge incontinence
the most bothersome (3.71 ± 0.44: 0–10 scale) (Figs. 1B and
2B). The ICIq-LUTSqol form was used to evaluate the impact
of urinary symptoms onQOL.This survey addressed impact of
LUTS on physical activities (questions 3–6), social activities
(questions 7–11), and emotional state (questions 12–16, 21).
Questions 17–20 addressed degree of urinary leakage and
question 22 evaluated overall impact on QOL (Figs. 1C and
2C). This global QOLquestion showedmoderate QOL impact
(4.47 ± 0.4: 0–10 scale) which was similar to the AUA-SS
bother score (2.89 ± 0.22: 0–6 scale) (Fig. 2D).
There were several statistically signiﬁcant differences in
survey results betweenmen and women. Fifty-nine percent of
women reported stress incontinence with cough or sneeze
versus 8% of men (P= 0.0001) based on the ICIq-UI Short
Form.Women reported signiﬁcantly more urge incontinence,
than men.Women reportedmore often having to wear pads to
stay dry than men, and women reported signiﬁcantly more
bother from having to wear pads than men. Overall, women
reported more urinary leakage than men. There was no
statistically signiﬁcant difference in the amount of bother
with respect to urinary leakage (not shown) (Table 2).
Twenty-eight patients (51%) reported two or more
comorbidities. Questionnaire responses from these patients
were compared to those with fewer than two comorbidities.
There was no signiﬁcant difference in answers between
the two groups in response to the ICIq-UI Short Form or
ICIq-OAB questionnaires (not shown). However, patients
with two or more comorbidities reported a greater impact of
LUTS on several domains including physical activities and
emotional state. In addition, there were differences in
individual questions within each domain, including work
and daily activities, relationships, depression, and self-image.
Though there was no difference in overall impact from
volume of urinary leakage, patients with greater than two
comorbidities reported more bother from having to change
clothing when wet due to urinary symptoms (Table 2).
No other questions showed a signiﬁcant difference. There
was no difference between groups in response to overall QOL
(ICIQ-LUTqol #22, 3.00 ± 0.60 vs. 4.11 ± 0.54, P= 0.173),
or in response to the AUA-SS bother score (2.46 ± 0.27 vs.
3.29 ± 0.32, P= 0.057).
Patients were also evaluated based on age. Groups were
divided into patients greater than or equal to the cohort's mean
TABLE 1 Patient information
Total Male Female P-value
Average age (years) 77 ± 0.7 76 ± 1.1 78 ± 1.2 0.228
N (%) 55 (100) 38 (69) 17 (31)
DM 11 (20.0) 8 (21.1) 3 (17.6) 1.000
CAD 12 (21.8) 10 (26.3) 2 (11.8) 0.304
COPD 0 (0) 0 (0) 0 (0) 1.000
HTN 26 (47.3) 16 (42.1) 10 (58.8) 0.381
Cancer 12 (21.8) 9 (23.7) 3 (17.6) 0.735
Seizures 2 (3.6) 1 (2.6) 1 (5.9) 0.527
Depression 12 (21.8) 7 (18.4) 5 (29.4) 0.482
Parkinson's 4 (7.3) 4 (10.5) 0 (0) 0.299
Alzheimer's 11 (20.0) 7 (18.4) 4 (23.5) 0.722
BPH/prostate cancer 7 (12.7) 7 (18.4) NA NA
DM, diabetes mellitus; CAD, coronary artery disease; COPD, chronic obstructive
pulmonary disease; HTN, hypertension; BPH, benign prostatic hyperplasia.
FIGURE 1 Symptom evaluation by questionnaire. (A) ICIq-UI Short
Form assessment of leakage frequency, volume, bother, and total score.
(B) ICIq-OAB Questionnaire assessing symptoms of daytime frequency,
nocturia, urgency, and urge incontinence. (C) ICIq-LUTSqol Question-
naire assessing quality-of-life impact of LUTS on physical activities,
social activities/relationships, and mood, as well as impact from urinary
leakage
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age of 77 (N= 30), or younger than the mean age (N= 25).
There was no signiﬁcant difference between groups in
response to the ICIq-UI Short Form total score (8.00 ± 0.89
vs. 9.56 ± 0.91 respectively, P= 0.23), or individual ques-
tions (not shown). However, the younger age group reported
more urinary urgency than the older age group. There were no
differences between groups in response to any of the
ICIq-LUTSqol questionnaire items (not shown). In addition,
the younger age group reported signiﬁcantly greater impact of
urinary symptoms on QOL (Table 2).
Urodynamics testing was offered to patients reporting
moderate-to-severe symptoms or bother. Urodynamics was
performed in 19 patients (35%) prior to any interventions for
urinary symptoms or iNPH. One hundred percent of patients
tested were found to have detrusor overactivity with 78.9%
having detrusor overactivity-associated incontinence (DOI),
and 10.5% of patients with urodynamic stress incontinence
(USI). Additional urodynamic results are shown in Table 3.
4 | DISCUSSION
iNPH consists of the classic triad of gait disturbance,
dementia, and urinary incontinence. Most studies have
focused on the dementia and gait disturbance manifestations
of this condition, with little attention paid to urinary
symptoms. To our knowledge, this is the ﬁrst prospective
study to provide a detailed characterization of the type,
severity, QOL impact, and urodynamic assessment of LUTS
in patients with new-onset iNPH prior to treatment.
This study revealed that 91% of patients reported some
degree of urinary incontinence, which occurred on average of
once/day, consisted of a small-to-moderate volume, and
caused a mild-to-moderate interference with everyday life. In
terms of OAB symptoms, 74.5% of patients with new-onset
iNPH reported experiencing urge incontinence. The most
common OAB symptom was nocturia, and the most
bothersome OAB symptom was urinary urge incontinence.
FIGURE 2 Bother associated with urinary symptoms. (A) ICIq-UI Short Form categorizing speciﬁc scenarios during which leakage occurs.
(B) ICIq-OAB Questionnaire assessing associated bother from daytime frequency, nocturia, urgency, and urge incontinence. (C) ICIq-LUTSquol
Questionnaire assessing associated bother from LUTS on physical activities, social activities/relationships, and mood, as well as impact from urinary
leakage. (D) ICIq-LUTSqol impact score (Question #22, 0–10 scale), and the AUA-SS (0–6 scale). Scores are plotted as percentage of total scale in
order to compare responses
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This aligns with prior smaller studies, which reported
detrusor overactivity in iNPH patients in 63–100%.9,17,18
Urinary urgency is thought to precede urge incontinence in
the progression of iNPH.6 This is signiﬁcant considering the
combination of early age of onset and mild symptoms/early
diagnosis are the best prognostic factors in terms of response
to shunt surgery.19
In our study, patients also reported that LUTS had only a
mild-to-moderate QOL impact. This stands in contrast to
QOL impact from gait andmemory impairment, which can be
quite profound in this population. In the classic study by P.M.
Black in 1980, 90% of patients had memory impairment, 85%
had gait disturbances, but only 55% had incontinence. Only
50% of their patients had the classic triad of dementia, gait
disturbances, and urinary incontinence. In that study, 54% of
patients with urinary incontinence, and 42% of patients
without incontinence had improvement in activity level
following shunting, conﬁrming that surgical management of
iNPH may improve overall activity, regardless of the
presence of urinary symptoms.20
Responses were also compared based on gender,
comorbidities, and age. Women reported signiﬁcantly more
stress incontinence, urge incontinence, and pad use. This may
reﬂect the higher prevalence of stress incontinence in this
population.21 Patients with two or more medical comorbid-
ities reported that urinary symptoms had a greater impact on
physical activities and emotional state than patients with
fewer comorbidities. This is consistent with other studies
showing that comorbidities can profoundly impact QOL,
especially in older adults.22–24 Interestingly, patients who
were younger than the mean age of 77 reported greater impact
from LUTS on physical activity, and signiﬁcantly worse
overall impact of LUTS on QOL. This may reﬂect a more
generalized acceptance of LUTS in very elderly patients25 or
TABLE 2 Signiﬁcant differences in LUTS by gender, medical comorbidities, and age
Questions Men (N= 38) Women (N= 17) P-value
ICIq-OAB
Effect ICIq-OAB: 6a 1.39 ± 0.16 2.18 ± 0.15 0.005
Bother ICIq-OAB: 6b 3.13 ± 0.54 5.00 ± 0.66 0.049
ICIq-LUTSqol
Leakage
Effect ICIq-LUTSqol: 17a 1.61 ± 0.18 3.06 ± 0.33 0.0001
ICIq-LUTSqol: 17a-20a 1.70 ± 0.10 2.15 ± 0.16 0.020
Bother ICIq-LUTSqol: 17b 0.84 ± 0.40 3.59 ± 1.00 0.003
≥2CM (N= 28) <2CM (N= 27)
ICIq-LUTSqol
Physical activities
Effect ICIq-LUTSqol: 4a 1.68 ± 0.18 1.19 ± 0.11 0.023
ICIq-LUTSqol: 3a-6a 1.62 ± 0.17 1.21 ± 0.09 0.042
Bother ICIq-LUTSqol: 4b 2.54 ± 0.63 0.48 ± 0.29 0.005
ICIq-LUTSqol: 3b-6b 1.91 ± 0.54 0.65 ± 0.30 0.047
Social activities
Effect ICIq-LUTSqol: 9a 1.8 ± 0.25 1.11 ± 0.08 0.019
Bother ICIq-LUTSqol: 9b 2.3 ± 0.72 0.32 ± 0.23 0.013
Emotional state
Effect ICIq-LUTSqol: 12a 1.71 ± 0.20 1.15 ± 0.07 0.010
ICIq-LUTSqol: 14a 1.61 ± 0.20 1.11 ± 0.06 0.020
ICIq-LUTSqol: 12-16,21a 1.77 ± 0.17 1.40 ± 0.06 0.046
Bother ICIq-LUTSqol: 12b 2.32 ± 0.62 0.74 ± 0.36 0.033
ICIq-LUTSqol: 14b 2.21 ± 0.67 0.41 ± 0.23 0.015
Leakage
Bother ICIq-LUTSqol: 19a 4.04 ± 0.64 2.11 ± 0.52 0.023
<77 yrs (N= 25) ≥77 yrs (N= 30)
ICIq-OAB
Effect ICIq-OAB: 5a 2.16 ± 0.19 1.5 ± 0.18 0.014
AUA-SS 3.64 ± 0.31 2.24 ± 0.25 0.0009
CM, comorbidities; yrs, years.
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the overall decline in participation in activities in this age
group.
Our ﬁnding of 100%DO in patients with new-onset iNPH
is consistent with ﬁndings by Sakakibara et al.6 reporting
95.2% of patients having DO, but higher than a reported rate
of 45.6% in a study by Campos-Juanatey et al.17 The common
ﬁnding of DO across multiple studies may reﬂect an altered
neurologic pathway in patients with iNPH. Our mean bladder
capacity was low at 202 mL, which is also similar to ﬁndings
by Sakakibara et al.6 and Campos-Juanatey et al.17
Limitations of this study are the use of surveys instead of
more objective measures of LUTS (pad tests and void
diaries). We administered pad tests and void diaries to all
patients; however, response rates and compliance with pad
collection and diaries were poor and did not offer evaluable
data. This may reﬂect the very advanced age of the population
coupled with varying degrees of cognitive impairment and
the fact that many patients came from long distances to this
highly specialized multi-disciplinary clinic. In addition, we
did not offer urodynamic testing except to patients who
reported at least moderate bother from LUTS based on
AUA-SS bother scale due to ethical concerns about invasivity
and potential complications in this extremely high-risk
cohort. Finally, we did not present results in patients in this
group who were followed and ultimately were treated with
VP shunting. Our preliminary data have shown a signiﬁcant
improvement in urinary symptoms across multiple domains
following shunting, possibly due, in part, to restoration of
blood ﬂow to the bilateral mid-cingulate cortex and other
cerebral micturition centers as recently demonstrated by
Sakakibara et al.26 However, this is beyond the scope of the
current investigation and is the subject of our next study.
5 | CONCLUSIONS
This study presents, to our knowledge, the ﬁrst prospective
characterization of LUTS in patients with new-onset iNPH
using validated surveys and urodynamics testing. The results
demonstrate that LUTS are highly prevalent, but bother is
much less signiﬁcant as compared to bother from gait
disturbances and memory impairment. Indeed, the results of
this study suggest that patients with iNPH who report LUTS
as the most impactful symptom in the NPH triad (gait
disturbances, memory impairment, and incontinence) should
TABLE 3 Urodynamic ﬁndings and diagnoses
Sensation FS (mL) FD (mL) SD (mL) BC (mL)
Mean 77 ± 12.9 123 ± 18.1 178 ± 36.0 202 ± 30.8
Sample (N) 13 15 13 19
Voiding function Qmax (mL/s) pDetQmax (cmH2O) Voided volume (mL) PVR (mL)
Mean 7 ± 1.0 64 ± 9.1 115 ± 19.1 88 ± 31.8
Sample (N) 18 17 19 19
Detrusor function Compliance (mL/cmH2O) 1st IDC volume (mL) Peak IDC pressure (cmH2O)
Mean 45 ± 9.9 164 ± 26.1 83 ± 9.9
Sample (N) 18 19 18
N %
Normal 0 0.0
Detrusor overactivity 19 100.0
Acontractile detrusor 0 0.0
Urethral function
Normal 7 38.9
Bladder outlet obstruction 9 50.0
Incompetent urethral closure mechanism 2 11.1
Incontinence
No 0 0.0
Yes 19 100.0
Incontinence type
DOI 15 78.9
USI 2 10.5
Both 2 10.5
FS, ﬁrst sensation; FD, ﬁrst desire; SD, strong desire; BC, bladder capacity; IDC, involuntary detrusor contraction; PVR, post-void residual; DOI, detrusor overactivity
incontinence; USI, urodynamic stress incontinence.
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be counseled that iNPH treatment may not improve their
LUTS. This is because the typical iNPH patient has only
mild-to-moderate bother and QOL impact from their LUTS.
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